摘要
一、造影剂肾病的定义造影剂肾病也称造影剂肾损害或造影剂所致急性肾损伤,其定义临床上并不完全统一,但最常使用的临床定义为使用造影剂后48 h内出现血肌酐上升超过其基础值的25%或超过0.5 mg/dl(44 μmol/L),且能除外造影外的其他原因.
出处
《中华临床医师杂志(电子版)》
CAS
2012年第19期5982-5985,共4页
Chinese Journal of Clinicians(Electronic Edition)
基金
天津医科大学科研基金(2004ky31)
参考文献19
-
1Gussenhoven MJ;Ravensbergen J;van Bockel JH.Renal dysfunction after angiography:a risk factor analysis in patients with peripheral vascular disease,1991.
-
2Hou SH;Bushinsky DA;Wish JB.Hospital-acquired renal insufficiency:a prospective study,1983.
-
3McCullough PA;Wolyn R;Rocher LL.Acute renal failure after coronary intervention:Incidence,risk factors,and relationship to mortality,1997.
-
4杨定位,贾汝汉,杨定平,丁国华,黄从新.Dietary hypercholesterolemia aggravates contrast media-induced nephropathy[J].Chinese Medical Journal,2004(4):542-546. 被引量:3
-
5Vogt B;Ferrari P;Schonholzer C.Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful,2001.
-
6Parfrey PS;Griffiths SM;Barrett BJ.Contrast material-induced renal failure in patients with diabetes mellitus,renal insufficiency,or both.A prospective controlled study,1989.
-
7Neumayer HH;Junge W;Kufner A.Prevention of radiocontrastmedia-induced nephrotoxicity by the calcium channel blocker nitrendipine:a prospective randomised clinical trial,1989.
-
8Heyman SN;Rosen S;Rosenberger C.Renal parenchymal hypoxia,hypoxia adaptation and the pathogenesis of radiocontrast nephropathy,2008.
-
9Nash K;Hafeez A;Hou S.Hospital-acquired renal insufficiency,2002.
-
10Solomon R;Werner C;Mann D.Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents,1994.
二级参考文献50
-
1汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
-
2Thomsen HS.Guidelines for contrast media from the European Soeiety of Urogenital Radioloy. American Journal of Roentgenology . 2003
-
3Isenbarger DW,Kent SM,O‘Malley PG, et al.Meta analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. The American Journal of Cardiology . 2003
-
4Cavusoglu E,Chhabra S,Marmur JD,et al.The prevention of con-trast-induced nephropathy in patients undergoing percutaneous coro-nary intervention. Minerva Cardioangiologica . 2004
-
5Tepel M,Zidek W.Acetylcysteine and contrast media nephropathy. Current Opinion in Nephrology and Hypertension . 2002
-
6Birck R,Krzossok S,Markowetz F,et al.Acetylcysteine for prevention of contrast nephropathy: meta-analysis. The Lancet . 2003
-
7Nash K,Hafeez A,Hou S,et al.Hospital-acquired renal insufficiency. American Journal of Kidney Diseases . 2002
-
8Kay J,Chow WH,Chan TM,et al.Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. Journal of the American Medical Association, The . 2003
-
9Alonso A,Lau J,Jaber BL,et al.Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. American Journal of Kidney Diseases . 2004
-
10Briguori C,Airoldi F,D’Andrea D,et al.Renal insufficiencyfollowing contrastmedia administration trial(REMEDIAL):arandomized comparison of 3 preventive strategies. Circulation . 2007
共引文献38
-
1马瑶,董艳芬.药物涂层球囊治疗周围动脉疾病的护理分析[J].世界临床医学,2018,12(1):62-62.
-
2周炳凤,施有为,徐少东,张晓红,付敏敏,周跟东.冠状动脉介入诊疗中普罗布考对造影剂造成的肾功能损害的干预研究[J].中华临床医师杂志(电子版),2012,6(18):90-93. 被引量:4
-
3Robin Arora,Shweta Kathuria,Nishant Jalandhara.Acute renal dysfunction in patients with alcoholic hepatitis[J].World Journal of Hepatology,2011,3(5):121-125. 被引量:4
-
4于俊秀,吴育连.泛影葡胺造影法建立肠梗阻手术指征的判定标准[J].中华急诊医学杂志,2004,13(11):780-781. 被引量:23
-
5段绍斌,邹琴,李英娟,彭佑铭,刘伏友,王予慧,许向青,姜文玲,刘映红,李军.高渗和低渗造影剂对鼠的肾毒性及福辛普利或替米沙坦的保护作用[J].中南大学学报(医学版),2007,32(5):812-818. 被引量:4
-
6杨定平,贾汝汉,丁国华,杨定位,熊晓玲.反向模式钠钙离子交换体抑制剂降低造影剂诱导的肾小管上皮细胞凋亡[J].中华急诊医学杂志,2008,17(7):713-716. 被引量:3
-
7李英娟,段绍斌,周晓蓉,王予慧,李军,彭佑铭,刘伏友.X线造影剂对高胆固醇血症大鼠的肾毒性及己酮可可碱的保护作用[J].中华肾脏病杂志,2008,24(10):730-735. 被引量:2
-
8邢丽娜,王大英,彭文.对比剂肾病的诊治及研究进展[J].中国临床实用医学,2010,4(2):259-260. 被引量:1
-
9章鲁艇,何军民.泛影葡胺联合肠梗阻导管治疗粘连性肠梗阻的疗效观察[J].全科医学临床与教育,2012,10(1):49-50. 被引量:1
-
10程凯,张杰,周晓光,王伟,许明伟.N-乙酰半胱氨酸对造影剂肾病预防效果的系统评价[J].临床误诊误治,2012,25(4):45-48. 被引量:5
同被引文献26
-
1邓海红,来青,周小娟.数字减影全脑血管造影及介入治疗术后并发症的观察及护理[J].实用神经疾病杂志,2005,8(6):89-90. 被引量:25
-
2Lopez AD,Murray CC.The global burden of disease:1990-2020[J].Nat Med,1998,4(11):1 241.
-
3Widimsky P,Bilkova D,Penicka M,et al.Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention.Five years’follow-up of the PRAGUE-2 Trial[J].Eur Heart J,2007,28(6):679.
-
4Solomon R,Dauerman HL.Contrast-induced acute kidney injury[J].Circulation,2010,122(23):2 451.
-
5Stacul F,van der Molen AJ,Reimer P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines[J].Eur Radiol,2011,21(12):2 527.
-
6Persson PB,Hansell P,Liss P.Pathophysiology of contrast medium-induced nephropathy[J].Kidney Int,2005,68(1):14.
-
7Fleming I,Kohlstedt K,Busse R.New FACEs to the renin-angiotensin system[J].Physiology:Bethesda,2005,20:91.
-
8Toprak O,Cirit M,Bayata S,et al.The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography[J].Anadolu Kardiyol Derg,2003,3(2):98.
-
9Umruddin Z,Moe K,Superdock K.ACE inhibitor or angiotensinⅡreceptor blocker use is a risk factor for contrast-induced nephropathy[J].J Nephrol,2012,25(5):776.
-
10Stacul F,van der Molen AJ,Reimer P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines[J].Eur Radiol,2011,21(12):2527.
引证文献3
-
1罗翔,刘地川.血管紧张素转化酶抑制剂对经皮冠脉介入术后造影剂肾病的影响[J].中国药房,2016,27(2):210-212. 被引量:3
-
2刘建光,姜红梅,王峥,刘忠志,雷靖安,韩琦,周玉涛,郭晓红.影响脑血管造影介入术后患者发生造影剂致急性肾损伤的相关因素分析[J].临床急诊杂志,2016,17(5):358-360. 被引量:5
-
3武子霞,张曼钰,李朝园,赵富浩,董淑慧,鲁胜,武雅文,杨定位.血必净注射液干预对造影剂急性肾损伤大鼠肾小管损伤的影响[J].中国中西医结合急救杂志,2024,31(4):447-450.
二级引证文献8
-
1闫志群,李六生,周志华,刘兰香.阿法骨化醇对IgA肾病患者血清TNF-α、IL-6、TGF-β1水平的影响[J].中国医药导报,2016,13(8):150-153. 被引量:4
-
2李珺,梁月娥,王湘,钱东翔,蔡名金.脑动脉瘤介入治疗后对比剂肾病的危险因素研究[J].广州医科大学学报,2016,44(5):34-36. 被引量:1
-
3熊琳,黄麟杰,李志浩,陈富超,朱军.临床药师基于循证药学方法对心力衰竭合并多种疾病患者的药学监护[J].中南药学,2018,16(5):695-699. 被引量:8
-
4李乐胜.前列地尔联合丹红注射液治疗老年冠心病PCI患者对肾功能及血清炎性因子的影响[J].系统医学,2018,3(5):56-58. 被引量:1
-
5袁野,刘鑫,景兴慧.影响血管造影术后急性肾损伤的危险因素分析[J].临床医学工程,2019,26(8):1159-1160.
-
6黄美兰,姚茹,党小宁.全程精细化护理联合水化疗法预防糖尿病亚急性期脑梗死患者数字减影全脑血管造影术后对比剂肾病的疗效[J].现代中西医结合杂志,2019,28(34):3854-3858. 被引量:21
-
7刘红娜,陈云爽.造影剂肾病研究进展[J].临床误诊误治,2021,34(1):108-112. 被引量:9
-
8迪力木拉提·阿不来提,买尔哈巴,穆叶赛·尼加提.PCI前后血管生成素-2水平与急性心梗伴CKD患者肾功能指标的相关性[J].临床急诊杂志,2021,22(8):529-533. 被引量:2
-
1张福亮,王金明.恩替卡韦治疗慢性乙型肝炎的临床研究概况[J].海峡药学,2015,27(1):179-182. 被引量:4
-
2王曙东,徐学银.川芎嗪临床研究概况[J].中医药研究,1999,15(6):56-58. 被引量:29
-
3唐集敏.前列地尔注射液治疗脑梗死的临床研究概况[J].中国现代药物应用,2013,7(15):223-224. 被引量:2
-
4胡卫东,杨宇,邓文.促胃肠动力药临床研究概况[J].中国药业,2008,17(10):77-78. 被引量:11
-
5艾宗耀.中医药治疗急性脑梗死的临床研究概况[J].中国中医急症,2014,23(11):2061-2063. 被引量:20
-
6郭小青,谌琦,王李雯.中医药治疗抑郁症的临床研究概况[J].现代中医药,2009,29(6):76-77. 被引量:8
-
7黄艺,周文强.针灸治疗血管性认知障碍临床研究概况[J].云南中医中药杂志,2014,35(12):77-79. 被引量:1
-
8郑艳.中西医治疗血管性痴呆临床研究概况[J].现代中西医结合杂志,2007,16(21):3119-3120. 被引量:2
-
9张殿全,孙忠人.中医药治疗发作性睡病的临床研究概况[J].中医药学报,2007,35(1):51-52. 被引量:1
-
10黄宝芸,廖哲安,方明厚.脑卒中后抑郁的临床研究概况[J].中华物理医学与康复杂志,2005,27(5):315-317. 被引量:11